Chong Kim

Chong Kim is a Principal Scientist and Director at Merck, leading bioanalytical activities and managing group members. They hold an MBA and have over 16 years of R&D experience, which includes roles at AstraZeneca, PPD, and the University of Virginia. Previously, Chong served as a Senior Scientist at AstraZeneca, managing early and late-phase programs and contributing to groundbreaking medication approvals. Chong's educational background includes a B.Sc. in Biochemistry from the University of Virginia and an M.Sc. in Chemistry from the University of North Carolina at Wilmington.